May 22, 2017
BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G, a novel injectable, antibiotic-eluting bone graft substitute
Media
May 19, 2017
Safety Review Committee Approves the Continued Evaluation of the 20 MBq/kg Betalutin® with 100 mg/m2 Lilotomab Regimen in Phase 2 Cohort in NHL
May 19, 2017
Nexstim Plc Updates the Timeline for its Supplementary E-FIT Phase III Trial in Stroke Rehabilitation
May 19, 2017
Wilson Therapeutics to present at Bioequity Europe
May 18, 2017
Targovax ASA: ASCO abstract released
May 17, 2017
Wilson Therapeutics AB (publ) Interim Report January 1 – March 31, 2017
May 16, 2017
Nordic Nanovector ASA: Invitation to First Quarter 2017 Results Presentation and Webcast
May 16, 2017
Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer
May 16, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports First Quarter 2017 Financial Results
May 11, 2017
Interim report January – March 2017
